Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.


Are you interested in exploring ongoing clinical trials for Malaria at the University of Alabama at Birmingham?


Following specialists treat  Malaria. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month




Specialty scores for Malaria


Source: In partnership with Genetic and Rare Diseases Information Center, funded by the National Center for Advancing Translational Sciences, and the National Human Genome Research Institute

Terms of Use


overview Question

What is malaria?

Malaria is a serious and sometimes fatal disease caused by a parasite that commonly infects a certain type of mosquito which feeds on humans. Infection with malaria parasites may result in a wide variety of symptoms, ranging from absent or very mild symptoms to severe disease and even death. People who get malaria are typically very sick with high fevers, shaking chills, and flu-like illness. In general, malaria is a curable disease if diagnosed and treated promptly and correctly. Treatment depends on many factors including disease severity, the species of malaria parasite causing the infection and the part of the world in which the infection was acquired.

Date Modified: 2011-05-12T11:06:00


Autosomal recessive inheritance

medical Products


Trade Name: Halfan™

Indication: Treatment of adults who can tolerate oral medication and who have mild to moderate malaria caused by Plasmodium falciparum or Plasmodium vivax.

Mefloquine HCl

Trade Name: Lariam

Indication: Treatment of acute malaria due to Plasmodium falciparum and Plasmodium vivax. Prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs.

Quinine sulfate

Trade Name: Qualaquin®

Indication: Treatment of uncomplicated Plasmodium falciparum malaria

FDA Approved Medicines

  • FDA approved artemether/lumefantrine, sold as Coartem, manufactured by Novartis for the treatment of malaria infections due to Plasmodium falciparum ( Falciparum Malaria | Malaria ) in year 2009.